These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5817055)

  • 1. [Studies on the concentration of cyclophosphamide (Endoxan) in the blood and tissues in patients with gynecological cancer, with special reference to optimum dosage].
    Tashiro K
    Gan No Rinsho; 1969 Apr; 15(4):433-8. PubMed ID: 5817055
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclophosphamide in high dosage forms as gynecologic neoplasm therapy].
    Tukiainen P
    Duodecim; 1968; 84(12):763-73. PubMed ID: 5685562
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chromosome aberrations in human peripheral lymphocytes following Endoxan massive-dose therapy of gynecological tumors].
    Schmid E; Bauchinger M
    Dtsch Med Wochenschr; 1968 Jun; 93(23):1149-51. PubMed ID: 5648360
    [No Abstract]   [Full Text] [Related]  

  • 4. [Methods of administration of antineoplastic drugs based on its concentration in the blood and various organs--cyclophosphamide].
    Kato T; Yakushiji M; Matsumoto M; Nunotani H
    Igaku Kenkyu; 1972 Nov; 42(3):159-66. PubMed ID: 4677171
    [No Abstract]   [Full Text] [Related]  

  • 5. [A study of the effect of endoxan on the serum cholinesterase activity in gynecologic carcinomas].
    Dacić Z
    Zentralbl Gynakol; 1965 Sep; 87(37):1249-56. PubMed ID: 5884968
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of steroid hormone on activation of Endoxan (cyclophosphamide).
    Hayakawa T; Kanai N; Yamada R; Kuroda R; Higashi H; Mogami H; Jinnai D
    Biochem Pharmacol; 1969 Jan; 18(1):129-35. PubMed ID: 4388633
    [No Abstract]   [Full Text] [Related]  

  • 7. [Endolymphatic therapy].
    Thepot JY
    Bull Mem Soc Chir Paris; 1971; 61(6):369-76. PubMed ID: 5152094
    [No Abstract]   [Full Text] [Related]  

  • 8. COMPARISON OF THYMINALKYLAMINE AND ENDOXAN EFFECT ON ADVANCED GYNECOLOGICAL CARCINOMAS IN A CONTROLLED CLINICAL TRIAL.
    DVORAK O; ELIS J; JELINEK J; KAFKA V; MUSIL J; SCHUBERT J
    Neoplasma; 1965; 12():87-91. PubMed ID: 14278335
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of lung cancer with special reference to combined therapy with mitomycin and endoxan].
    Oka S; Watanabe M; Kato S; Tamagawa S
    Gan No Rinsho; 1966 May; 12(5):271-7. PubMed ID: 6010949
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum enzyme during endoxan treatment].
    Dacić Z
    Med Klin; 1966 Apr; 61(16):642-4. PubMed ID: 5988317
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ambulatory use of cisplatin. Preliminary considerations].
    de Oliveira Filho JA; da Cunha FM
    Rev Paul Med; 1983; 101(5):199-202. PubMed ID: 6200911
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats.
    Powers JF; Sladek NE
    Cancer Res; 1983 Mar; 43(3):1101-6. PubMed ID: 6825082
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytological picture of urine sediment in gynecologic radiotherapy, endoxan and bleomycin therapy].
    Schrage R
    Arch Gynakol; 1975 Nov; 219(1-4):70-1. PubMed ID: 55112
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of lung cancer with Endoxan, with reference to the effect of massive intermittent administration].
    Matsuda M; Nishihara H; Komatsu T; Hattori S; Terasawa T
    Saishin Igaku; 1967 Aug; 22(8):1808-20. PubMed ID: 6081168
    [No Abstract]   [Full Text] [Related]  

  • 15. [1st results of in-vitro testing of carcinomas against "activated endoxan"].
    Bastert G; Hohorst HJ; Schmidt-Matthiesen H; Voelcker G
    Arch Gynakol; 1975 Nov; 219(1-4):183-5. PubMed ID: 1243283
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with Neo AF 2 in gynecological cancer].
    Bracali R; Mazza A; Valli P
    Minerva Ginecol; 1966 Jun; 18(12):708-10. PubMed ID: 5989981
    [No Abstract]   [Full Text] [Related]  

  • 17. The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.
    Momerency G; Van Cauwenberghe K; Slee PH; Van Oosterom AT; De Bruijn EA
    Biol Mass Spectrom; 1994 Mar; 23(3):149-58. PubMed ID: 8148406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative management in primary genital lymphomas: the role of chemotherapy.
    Signorelli M; Maneo A; Cammarota S; Isimbaldi G; Garcia Parra R; Perego P; Maria Pogliani E; Mangioni C
    Gynecol Oncol; 2007 Feb; 104(2):416-21. PubMed ID: 17049970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of cyclophosphamide-C14 by various marine species.
    Mellett LB; el-Dareer SM; Rall DP; Adamson RH
    Arch Int Pharmacodyn Ther; 1969 Jan; 177(1):60-70. PubMed ID: 5353883
    [No Abstract]   [Full Text] [Related]  

  • 20. Intermediate dose single agent cyclophosphamide chemotherapy of advanced breast cancer.
    Bramwell VH; Howell A; Anderson H; Rankin EM
    Clin Oncol; 1983 Sep; 9(3):251-6. PubMed ID: 6617000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.